ChiCTR2100051946 版本V1.5 版本创建时间2022/04/26 21:49:18 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100051946 

最近更新日期:

Date of Last Refreshed on:

2022-04-26 21:43:49 

注册时间:

Date of Registration:

2021-10-09 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

不同体位对无痛内镜检查安全性的评价

Public title:

Evaluation of different body positions on the safety of painless endoscopy

注册题目简写:

English Acronym:

研究课题的正式科学名称:

不同体位对无痛内镜检查安全性的评价

Scientific title:

Evaluation of different body positions on the safety of painless endoscopy

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

蒋柯 

研究负责人:

蒋柯 

Applicant:

Jiang Ke 

Study leader:

Jiang Ke 

申请注册联系人电话:

Applicant telephone:

+86 13232742117

研究负责人电话:

Study leader's telephone:

+86 13232742117

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1593260045@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1593260045@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

贵州省贵阳市贵医街28号

研究负责人通讯地址:

贵州省贵阳市贵医街28号

Applicant address:

28 Guiyi street, Guiyang, Guizhou

Study leader's address:

28 Guiyi street, Guiyang, Guizhou

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

贵州医科大学附属医院

Applicant's institution:

Affiliated Hospital of Guizhou Medical University

研究负责人所在单位:

贵州医科大学附属医院

Affiliation of the Leader:

Affiliated Hospital of Guizhou Medical University

是否获伦理委员会批准:

否/No

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

贵州医科大学附属医院

Primary sponsor:

Affiliated Hospital of Guizhou Medical University

研究实施负责(组长)单位地址:

贵州省贵阳市贵医街28号

Primary sponsor's address:

28 Guiyi street, Guiyang, Guizhou

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

贵州

市(区县):

贵阳

Country:

China

Province:

Guiyang

City:

Guangzhou

单位(医院):

贵州医科大学附属医院

具体地址:

云岩区贵医街28号

Institution
hospital:

Affiliated Hospital of Guizhou Medical University

Address:

28 Guiyi Street, Yunyan District

经费或物资来源:

Source(s) of funding:

No

Target disease:

Digestive tract diseases

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

主要目的:研究asa1-2级患者,不同体位角度对无痛内镜检查围术期反流误吸及通气的影响。  

Objectives of Study:

Main purpose: to study the effects of different body positions on perioperative reflux aspiration and ventilation in patients with asa1-2.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.ASA分级1-2级;
2.计划行胃镜检查及胃镜下息肉切除;
3.年龄18-65岁;
4.BMI18-23.9;
5.患者及家属对研究知情同意。

Inclusion criteria

1. ASA classification 1-2;
2. Plan gastroscopy and polypectomy under gastroscopy;
3. Aged 18 to 65 years;
4. BMI18-23.9;
5. Patients and their families gave informed consent to the study.

排除标准:

1.长期酗酒对麻醉药物耐受者;
2.对本研究中使用药物过敏者;
3.胃排空延迟患者;
4.贲门失弛缓综合征;
5.胃食管反流综合征;
6.患者无法配合的;
7.禁饮禁食时间不足8小时者;
8.使用导致食管括约肌松弛药物的患者;
9.长期疼痛焦虑的病人;
10.检查前氧饱和度≤95%的患者;
11.有困难气道及患有严重呼吸道病变(阻塞型睡眠呼吸暂停综合征、张口障碍、颈项或下颌活动受限、病态肥胖,急性呼吸道感染、慢性阻塞性肺疾病急性发作期、未受控制的哮喘等);
12.术前访视血压≥180/110 mm Hg(WHO-ISH 高血压指南 3 级高血压);
13.胃肠道手术病史患者;
14.30 天内参加其他研究的患者;
15.麻醉偏浅导致患者出现严重呛咳反应;
16.贫血患者。

Exclusion criteria:

1. Long-term alcoholism and tolerance to narcotic drugs;
2. Those who are allergic to the drugs used in this study;
3. Patients with delayed gastric emptying;
4. Achalasia syndrome;
5. Gastroesophageal reflux syndrome;
6. The patient cannot cooperate;
7. Those who fasted for less than 8 hours;
8. Patients using drugs that cause esophageal sphincter relaxation;
9. Patients with long-term pain and anxiety;
10. Patients with oxygen saturation less than or equal to 95% before examination;
11. Difficult airway and severe respiratory disease (obstructive sleep apnea syndrome, mouth opening disorder, restricted neck or jaw movement, morbid obesity, acute respiratory infection, acute exacerbation of chronic obstructive pulmonary disease, uncontrolled asthma, etc.);
12. Preoperative visit blood pressure >=180/110 mm Hg (WHO-ISH hypertension guideline grade 3 hypertension);
13. Patients with a history of gastrointestinal surgery;
14. Patients enrolled in other studies within 30 days;
15. The shallow anesthesia causes the patient to have a severe coughing reaction;
16. Anemia patients.

研究实施时间:

Study execute time:

From 2021-10-09 00:00:00 To 2021-12-09 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-10-09 00:00:00 To 2021-12-09 00:00:00  

干预措施:

Interventions:

组别:

Case series

样本量:

100

Group:

Case series

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

贵州 

市(区县):

 

Country:

China 

Province:

Guizhou 

City:

 

单位(医院):

贵州医科大学附属医院 

单位级别:

三级甲等 

Institution
hospital:

Affiliated Hospital of Guizhou Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

胃蛋白酶

指标类型:

主要指标

Outcome:

Pepsin

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

通气情况

指标类型:

次要指标

Outcome:

Ventilation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

气管和咽喉分泌物

组织:

Sample Name:

Tracheal and throat secretion

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由实验组长使用随机数表产生随机序列

Randomization Procedure (please state who generates the random number sequence and by what method):

The experimental team leader uses the random number table to generate a random sequence

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

采用临床试验公共管理平台并向公众开放查询,也可向研究者直接索取

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The public management platform of clinical trials is adopted and the inquiry is open to the public, and it can also be obtained directly from researchers

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集分为病例报告表和SAS统计软件管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection is divided into case report form and SAS statistical software management

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-10-09 23:06:52